Royal-Bank-Of-Canada

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
24,810
Total Value
350517986000
Accession Number
0001140361-25-019231
Form Type
13F-HR
Manager Name
Royal-Bank-Of-Canada
Data Enrichment
78% identified
19,259 identified5,551 unidentified

Holdings

24,810 positions • $350.5B total value
Manager:
Search and click to pin securities to the top
Page 310 of 331
Contineum Therapeutics, Inc.
Shares:264
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
886364173
Shares:24
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
Vistagen Therapeutics, Inc.
Shares:911
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
FARMER BROTHERS CO
Shares:834
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
Cipher Mining Inc.
Shares:832
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
Kenon Holdings Ltd.
Shares:58
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
75526L878
Shares:56
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
Sight Sciences, Inc.
Shares:1.0K
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
78468R515
Shares:102
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
251936100
Shares:8.3K
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
Neonode Inc.
Shares:190
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
78468R440
Shares:71
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
Acrivon Therapeutics, Inc.
Shares:849
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
02376RAF9
Shares:—
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
38149W531
Shares:100
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
Actinium Pharmaceuticals, Inc.
Shares:1.3K
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
EMX Royalty Corp
Shares:744
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
690145206
Shares:185
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
Ispire Technology Inc.
Shares:868
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)
74347R214
Shares:40
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$350.5B)